# A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

> **NCT07288203** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Iovance Biotherapeutics, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Melanoma (Skin Cancer)
- Unresectable Melanoma
- Metastatic Melanoma

## Interventions

- **BIOLOGICAL:** Lifileucel

## Key facts

- **NCT ID:** NCT07288203
- **Lead sponsor:** Iovance Biotherapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-28
- **Primary completion:** 2032-12
- **Final completion:** 2033-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07288203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07288203, "A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07288203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*